Ángel Ortega

762 total citations
23 papers, 503 citations indexed

About

Ángel Ortega is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Pharmacology. According to data from OpenAlex, Ángel Ortega has authored 23 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Ángel Ortega's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Natural Antidiabetic Agents Studies (4 papers) and Pharmacology and Obesity Treatment (2 papers). Ángel Ortega is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Natural Antidiabetic Agents Studies (4 papers) and Pharmacology and Obesity Treatment (2 papers). Ángel Ortega collaborates with scholars based in Venezuela, Colombia and United States. Ángel Ortega's co-authors include Valmore Bermúdez, Milagros Rojas, Joselyn Rojas, Juan Salazar, Mervin Chávez-Castillo, Manuel Nava, Maricarmen Chacín, Juan Bautista De Sanctis, Carla Navarro and Lissé Angarita and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and International Journal of Environmental Research and Public Health.

In The Last Decade

Ángel Ortega

23 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ángel Ortega Venezuela 11 145 110 70 69 47 23 503
Angelika D. Manthripragada United States 12 136 0.9× 79 0.7× 69 1.0× 48 0.7× 76 1.6× 19 977
Roya Naderi Iran 15 163 1.1× 128 1.2× 60 0.9× 70 1.0× 42 0.9× 60 580
Trine Henriksen Denmark 15 337 2.3× 142 1.3× 78 1.1× 70 1.0× 37 0.8× 25 777
Yanyang Tu China 12 231 1.6× 133 1.2× 35 0.5× 49 0.7× 43 0.9× 29 639
Lucie Vávřová Czechia 11 140 1.0× 78 0.7× 44 0.6× 69 1.0× 31 0.7× 17 615
Ismaeel Bin‐Jaliah Saudi Arabia 15 111 0.8× 97 0.9× 20 0.3× 71 1.0× 44 0.9× 48 631
Ahmet Belce Türkiye 15 183 1.3× 123 1.1× 34 0.5× 29 0.4× 26 0.6× 32 604
Jana Kodydková Czechia 8 127 0.9× 74 0.7× 31 0.4× 64 0.9× 29 0.6× 13 537
Man‐Lung Fung Hong Kong 15 212 1.5× 194 1.8× 35 0.5× 53 0.8× 37 0.8× 22 881
Hanna Pawluk Poland 16 224 1.5× 168 1.5× 21 0.3× 73 1.1× 32 0.7× 33 883

Countries citing papers authored by Ángel Ortega

Since Specialization
Citations

This map shows the geographic impact of Ángel Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángel Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángel Ortega more than expected).

Fields of papers citing papers by Ángel Ortega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángel Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángel Ortega. The network helps show where Ángel Ortega may publish in the future.

Co-authorship network of co-authors of Ángel Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Ángel Ortega. A scholar is included among the top collaborators of Ángel Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángel Ortega. Ángel Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salazar, Juan, et al.. (2025). Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications. Pharmaceuticals. 18(2). 247–247. 5 indexed citations
2.
Ortega, Ángel, et al.. (2025). Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications. Molecules. 30(10). 2212–2212. 2 indexed citations
3.
Ortega, Ángel, Juan Salazar, Milagros Rojas, et al.. (2022). Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy. International Journal of Molecular Sciences. 23(8). 4196–4196. 10 indexed citations
4.
Rojas, Milagros, Mervin Chávez-Castillo, Pablo Durán, et al.. (2022). Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic Treatments. Current Pharmaceutical Design. 28(33). 2725–2741. 4 indexed citations
5.
Navarro, Carla, et al.. (2022). Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics. 14(6). 1303–1303. 85 indexed citations
6.
Ortega, Ángel, Carla Navarro, Milagros Rojas, et al.. (2021). The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. International Journal of Molecular Sciences. 23(1). 430–430. 51 indexed citations
7.
Chávez-Castillo, Mervin, Ángel Ortega, Lorena Cudris–Torres, et al.. (2021). Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?. International Journal of Molecular Sciences. 22(19). 10370–10370. 36 indexed citations
8.
D’Marco, Luis, José Luis Górriz, Manuel Nava, et al.. (2021). SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence. Journal of Diabetes Research. 2021. 1–17. 14 indexed citations
9.
Bermúdez, Valmore, Juan Salazar, Manuel Nava, et al.. (2021). Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela. Journal of Obesity. 2021. 1–7. 9 indexed citations
10.
Bermúdez, Valmore, Juan Salazar, María Sofía Martínez, et al.. (2021). Age-specific waist circumference cutoff-points for abdominal obesity diagnosis: a personalized strategy for a large Venezuelan population. Journal of Diabetes & Metabolic Disorders. 20(1). 217–227. 1 indexed citations
11.
Salazar, Juan, Carla Navarro, Ángel Ortega, et al.. (2021). Advanced Glycation End Products: New Clinical and Molecular Perspectives. International Journal of Environmental Research and Public Health. 18(14). 7236–7236. 40 indexed citations
12.
Rojas, Milagros, Mervin Chávez-Castillo, Ángel Ortega, et al.. (2021). Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World Journal of Diabetes. 12(6). 745–766. 62 indexed citations
13.
Chávez-Castillo, Mervin, Victoria Núñez, Milagros Rojas, et al.. (2020). Exploring Phytotherapeutic Alternatives for Obesity, Insulin Resistance and Diabetes Mellitus. Current Pharmaceutical Design. 26(35). 4430–4443. 5 indexed citations
14.
Chávez-Castillo, Mervin, Ángel Ortega, Pablo Durán, et al.. (2020). Phytotherapy for Cardiovascular Disease: A Bench-to-Bedside Approach. Current Pharmaceutical Design. 26(35). 4410–4429. 8 indexed citations
15.
Rojas, Milagros, Mervin Chávez-Castillo, Ángel Ortega, et al.. (2020). Chronobiology and Chronotherapy in Depression: Current Knowledge and Chronotherapeutic Promises. 16(3). 179–193. 1 indexed citations
16.
Chávez-Castillo, Mervin, Manuel Nava, Ángel Ortega, et al.. (2020). Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease. Current Neuropharmacology. 18(11). 1138–1153. 12 indexed citations
17.
Bermúdez, Valmore, Juan Salazar, Manuel Nava, et al.. (2020). Análisis clínico-epidemiológico de las subfracciones HDL2 y HDL3 en adultos de la ciudad de Maracaibo, Venezuela. Revista Peruana de Medicina Experimental y Salud Pública. 37(3). 412–22. 1 indexed citations
18.
Chávez-Castillo, Mervin, Victoria Núñez, Manuel Nava, et al.. (2019). Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. Advances in Pharmacological Sciences. 2019. 1–20. 40 indexed citations
19.
Salazar, Juan, Mervin Chávez-Castillo, Joselyn Rojas, et al.. (2019). Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?. Current Diabetes Reviews. 16(7). 733–749. 9 indexed citations
20.
Ortega, Ángel, et al.. (1991). [Anthropometric changes and nitrogen balance in patients with morbid obesity treated with very low calorie diet].. PubMed. 96(11). 401–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelika D. Manthripragada Breakdown of academic impact, for papers by Roya Naderi Breakdown of academic impact, for papers by Trine Henriksen Breakdown of academic impact, for papers by Yanyang Tu Breakdown of academic impact, for papers by Lucie Vávřová Breakdown of academic impact, for papers by Ismaeel Bin‐Jaliah Breakdown of academic impact, for papers by Ahmet Belce Breakdown of academic impact, for papers by Jana Kodydková Breakdown of academic impact, for papers by Man‐Lung Fung Breakdown of academic impact, for papers by Hanna Pawluk
Rankless by CCL
2026